scholarly journals Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana

2021 ◽  
Vol 37 (1) ◽  
pp. 16-23
Author(s):  
Catherine K. Koofhethile ◽  
Sikhulile Moyo ◽  
Kenanao P. Kotokwe ◽  
Charlotte Chang ◽  
Patrick Mokgethi ◽  
...  
PLoS ONE ◽  
2010 ◽  
Vol 5 (3) ◽  
Author(s):  
Hong Zhang ◽  
Damien C. Tully ◽  
Federico G. Hoffmann ◽  
Jun He ◽  
Chipepo Kankasa ◽  
...  

2019 ◽  
Vol 77 (4) ◽  
Author(s):  
Chinnambedu Ravichandran Swathirajan ◽  
Pannerselvam Nandagopal ◽  
Ramachandran Vignesh ◽  
Aylur Kailasam Srikrishnan ◽  
Rajat Goyal ◽  
...  

ABSTRACT HIV-1 vaccine functioning relies on successful induction of broadly neutralizing antibodies (bNAbs). CXCR3− circulatory T-follicular helper (cTfh) cells are necessary for inducing B-cells for generating bNAbs. Recent studies have suggested that CXCR3+ Tfh cells might also influence bNAb production. Plasma samples from 34 ART-Naïve HIV-1 infected individuals [long-term nonprogressors (LTNP)—19; Progressors—13] were tested against a heterologous virus panel (n = 11) from subtypes A, B, C, G, AC, BC and AE. Frequencies of CXCR3+ and CXCR3− cTfh-like cells in peripheral circulation were studied using flow cytometry. LTNP showed significantly lower CXCR3+ and higher CXCR3− cTfh-like cell frequencies, while neutralization breadth was observed to be broader in progressors. A positive correlation was observed between bNAb breadth and potency with CXCR3+PD-1+ cTfh-like cells in LTNP. Based on neutralization breadth, 9 HIV-1 infected individuals were classified as ‘top neutralizers’ and 23 as ‘low neutralizers’ and they did not show any correlations with CXCR3+ and CXCR3− cTfh-like cells. These preliminary data suggest that CXCR3+ similar to CXCR3− might possess significant functional properties for driving B-cells to produce bNAbs. Hence, an HIV vaccine which is capable of optimal induction of CXCR3+ cTfh cells at germinal centers might confer superior protection against HIV.


PLoS ONE ◽  
2010 ◽  
Vol 5 (3) ◽  
Author(s):  
Hong Zhang ◽  
Damien C. Tully ◽  
Federico G. Hoffmann ◽  
Jun He ◽  
Chipepo Kankasa ◽  
...  

1999 ◽  
Vol 31 (4) ◽  
pp. 337-343 ◽  
Author(s):  
Lars Navér, Anneka Ehrnst, Erik Bel
Keyword(s):  

AIDS ◽  
2001 ◽  
Vol 15 (15) ◽  
pp. 1985-1991 ◽  
Author(s):  
Pythia T. Nieuwkerk ◽  
Elisabeth H. Gisolf ◽  
Monique H.E. Reijers ◽  
Joep M.A. Lange ◽  
Sven A. Danner

Vaccine ◽  
2008 ◽  
Vol 26 (40) ◽  
pp. 5196-5201 ◽  
Author(s):  
Paolo Palma ◽  
Maria Luisa Romiti ◽  
Caterina Cancrini ◽  
Simone Pensieroso ◽  
Carla Montesano ◽  
...  

2010 ◽  
Vol 51 (2) ◽  
pp. 214-224 ◽  
Author(s):  
C. Dollfus ◽  
J. Le Chenadec ◽  
A. Faye ◽  
S. Blanche ◽  
N. Briand ◽  
...  

2020 ◽  
Vol 276 ◽  
pp. 113778 ◽  
Author(s):  
Alessia Bertoldi ◽  
Vanessa D’Urbano ◽  
Isabella Bon ◽  
Annelies Verbon ◽  
Casper Rokx ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document